Skip to main content
Top
Published in: BMC Cancer 1/2007

Open Access 01-12-2007 | Case report

Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report

Authors: Giacomo Puppa, Makio Shozu, Tiziana Perin, Kazuhito Nomura, Annunziata Gloghini, Elio Campagnutta, Vincenzo Canzonieri

Published in: BMC Cancer | Issue 1/2007

Login to get access

Abstract

Background

Malignant transformation of adenomyosis is a very rare event. Only about 30 cases of this occurrence have been documented till now.

Case presentation

The patient was a 57-year-old woman with a slightly enlarged uterus, who underwent total hysterectomy and unilateral adnexectomy. On gross inspection, the uterine wall displayed a single nodule measuring 5 cm and several small gelatinous lesions. Microscopic examination revealed a common leiomyoma and multiple adenomyotic foci. A few of these glands were transformed into a moderately differentiated adenocarcinoma. The endometrium was completely examined and tumor free. The carcinoma was, therefore, considered to be an endometrioid adenocarcinoma arising from adenomyosis. Four months later, an ultrasound scan revealed enlarged pelvic lymph nodes: a cytological diagnosis of metastatic adenocarcinoma was made.
Immunohistochemical studies showed an enhanced positivity of the tumor site together with the neighbouring adenomyotic foci for estrogen receptors, aromatase, p53 and COX-2 expression when compared to the distant adenomyotic glands and the endometrium. We therefore postulate that the neoplastic transformation of adenomyosis implies an early carcinogenic event involving p53 and COX-2; further tumor growth is sustained by an autocrine-paracrine loop, based on a modulation of hormone receptors as well as aromatase and COX-2 local expression.

Conclusion

Adenocarcinoma in adenomyosis may be affected by local hormonal influence and, despite its small size, may metastasize.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koshiyama M, Okamoto T, Ueta M: The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri. Cancer Detect Prev. 2004, 28: 94-98. 10.1016/j.cdp.2003.12.008.CrossRefPubMed Koshiyama M, Okamoto T, Ueta M: The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri. Cancer Detect Prev. 2004, 28: 94-98. 10.1016/j.cdp.2003.12.008.CrossRefPubMed
2.
go back to reference Marcus CC: Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. Am J Obstet Gynecol. 1961, 82: 408-416.CrossRefPubMed Marcus CC: Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. Am J Obstet Gynecol. 1961, 82: 408-416.CrossRefPubMed
3.
go back to reference Sampson JA: Endometrial carcinoma of the ovary arising in endometrial tissue of that organ. Archives of Surgery. 1925, 10: 1-72.CrossRef Sampson JA: Endometrial carcinoma of the ovary arising in endometrial tissue of that organ. Archives of Surgery. 1925, 10: 1-72.CrossRef
4.
go back to reference Couto D, Mota F, Silva T, C O: Adenocarcinoma arising in adenomyosis: report of an unusual case. Acta Obstet Gynecol Scand. 2004, 83: 406-408. 10.1111/j.0001-6349.2004.00025b.x.CrossRefPubMed Couto D, Mota F, Silva T, C O: Adenocarcinoma arising in adenomyosis: report of an unusual case. Acta Obstet Gynecol Scand. 2004, 83: 406-408. 10.1111/j.0001-6349.2004.00025b.x.CrossRefPubMed
5.
go back to reference Hernandez E, Woodruff JD: Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol. 1980, 138: 827-832.PubMed Hernandez E, Woodruff JD: Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol. 1980, 138: 827-832.PubMed
6.
go back to reference Koshiyama M, Suzuki A, Ozawa M, Fujita K, Sakakibara A, Kawamura M, Takahashi S, Fujii H, Hirano T, Okagaki A, Nagano T, Ban C: Adenocarcinomas arising from uterine adenomyosis: a report of four cases. Int J Gynecol Pathol. 2002, 21: 239-245. 10.1097/00004347-200207000-00006.CrossRefPubMed Koshiyama M, Suzuki A, Ozawa M, Fujita K, Sakakibara A, Kawamura M, Takahashi S, Fujii H, Hirano T, Okagaki A, Nagano T, Ban C: Adenocarcinomas arising from uterine adenomyosis: a report of four cases. Int J Gynecol Pathol. 2002, 21: 239-245. 10.1097/00004347-200207000-00006.CrossRefPubMed
7.
go back to reference Kuwashima Y, Uehara T, Kishi K, Tajima H, Shiromizu K, Matsuzawa M, Takayama S: Intramural adenocarcinoma of the uterus, arisen from adenomyosis uteri, showing unique histologic appearances. Report of two cases. Eur J Gynaecol Oncol. 1994, 15: 418-423.PubMed Kuwashima Y, Uehara T, Kishi K, Tajima H, Shiromizu K, Matsuzawa M, Takayama S: Intramural adenocarcinoma of the uterus, arisen from adenomyosis uteri, showing unique histologic appearances. Report of two cases. Eur J Gynaecol Oncol. 1994, 15: 418-423.PubMed
8.
go back to reference Rubod C, Narducci F, Delattre C, Decocq J, Verbert A, Delahousse G: Endometrioid adenocarcinoma arising from adenomyosis. A case report and literature review. J Gynecol Obstet Biol Reprod (Paris). 2004, 33: 140-144.CrossRef Rubod C, Narducci F, Delattre C, Decocq J, Verbert A, Delahousse G: Endometrioid adenocarcinoma arising from adenomyosis. A case report and literature review. J Gynecol Obstet Biol Reprod (Paris). 2004, 33: 140-144.CrossRef
9.
go back to reference Sasaki T, Sugiyama T, Nanjo H, Hoshi N, Murakami M, Sugita A, Takahashi M, Kawamura K, Ono I, Masuda H: Endometrioid adenocarcinoma arising from adenomyosis: report and immunohistochemical analysis of an unusual case. Pathol Int. 2001, 51: 308-313. 10.1046/j.1440-1827.2001.01200.x.CrossRefPubMed Sasaki T, Sugiyama T, Nanjo H, Hoshi N, Murakami M, Sugita A, Takahashi M, Kawamura K, Ono I, Masuda H: Endometrioid adenocarcinoma arising from adenomyosis: report and immunohistochemical analysis of an unusual case. Pathol Int. 2001, 51: 308-313. 10.1046/j.1440-1827.2001.01200.x.CrossRefPubMed
10.
go back to reference Takai N, Akizuki S, Nasu K, Etoh Y, Miyakawa I: Endometrioid adenocarcinoma arising from adenomyosis. Gynecol Obstet Invest. 1999, 48: 141-144. 10.1159/000010139.CrossRefPubMed Takai N, Akizuki S, Nasu K, Etoh Y, Miyakawa I: Endometrioid adenocarcinoma arising from adenomyosis. Gynecol Obstet Invest. 1999, 48: 141-144. 10.1159/000010139.CrossRefPubMed
11.
go back to reference Woodruff JD, Erozan YS, Genadry R: Adenocarcinoma arising in adenomyosis detected by atypical cytology. Obstet Gynecol. 1986, 67: 145-148.PubMed Woodruff JD, Erozan YS, Genadry R: Adenocarcinoma arising in adenomyosis detected by atypical cytology. Obstet Gynecol. 1986, 67: 145-148.PubMed
12.
go back to reference Takeuchi K, Yamanaka Y, Hamana S, Ohara N, Maruo T: Invasive adenocarcinoma arising from uterine adenomyosis involving the rectosigmoid colon. Int J Gynecol Cancer. 2004, 14: 1004-1006. 10.1111/j.1048-891X.2004.14541.x.CrossRefPubMed Takeuchi K, Yamanaka Y, Hamana S, Ohara N, Maruo T: Invasive adenocarcinoma arising from uterine adenomyosis involving the rectosigmoid colon. Int J Gynecol Cancer. 2004, 14: 1004-1006. 10.1111/j.1048-891X.2004.14541.x.CrossRefPubMed
13.
go back to reference Zanetta GM, Webb MJ, Li H, Keeney GL: Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 2000, 79: 18-22. 10.1006/gyno.2000.5905.CrossRefPubMed Zanetta GM, Webb MJ, Li H, Keeney GL: Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 2000, 79: 18-22. 10.1006/gyno.2000.5905.CrossRefPubMed
14.
go back to reference Giordano G, Gnetti L, Merisio C, Melpignano M: Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas. 2007, 56: 190-197. 10.1016/j.maturitas.2006.08.002.CrossRefPubMed Giordano G, Gnetti L, Merisio C, Melpignano M: Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas. 2007, 56: 190-197. 10.1016/j.maturitas.2006.08.002.CrossRefPubMed
15.
go back to reference Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, Lin Z: Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol. 2005, 95: 57-62. 10.1016/j.jsbmb.2005.04.012.CrossRefPubMed Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, Lin Z: Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol. 2005, 95: 57-62. 10.1016/j.jsbmb.2005.04.012.CrossRefPubMed
16.
go back to reference Shozu M, Murakami K, Inoue M: Aromatase and leiomyoma of the uterus. Semin Reprod Med. 2004, 22: 51-60. 10.1055/s-2004-823027.CrossRefPubMed Shozu M, Murakami K, Inoue M: Aromatase and leiomyoma of the uterus. Semin Reprod Med. 2004, 22: 51-60. 10.1055/s-2004-823027.CrossRefPubMed
17.
go back to reference Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Honjo H: Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Gynecol Obstet Invest. 1999, 48 Suppl 1: 21-28. 10.1159/000052865.CrossRefPubMed Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Honjo H: Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Gynecol Obstet Invest. 1999, 48 Suppl 1: 21-28. 10.1159/000052865.CrossRefPubMed
18.
go back to reference Attar E, Bulun SE: Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006, 12: 49-56. 10.1093/humupd/dmi034.CrossRefPubMed Attar E, Bulun SE: Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006, 12: 49-56. 10.1093/humupd/dmi034.CrossRefPubMed
19.
go back to reference Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE: Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 1998, 83: 4474-4480. 10.1210/jc.83.12.4474.PubMed Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE: Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 1998, 83: 4474-4480. 10.1210/jc.83.12.4474.PubMed
20.
go back to reference Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW: Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol. 2000, 13: 379-388. 10.1038/modpathol.3880062.CrossRefPubMed Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW: Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol. 2000, 13: 379-388. 10.1038/modpathol.3880062.CrossRefPubMed
21.
go back to reference Morrison C, Zanagnolo V, Ramirez N, Cohn DE, Kelbick N, Copeland L, Maxwell GL, Fowler JM: HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J Clin Oncol. 2006, 24: 2376-2385. 10.1200/JCO.2005.03.4827.CrossRefPubMed Morrison C, Zanagnolo V, Ramirez N, Cohn DE, Kelbick N, Copeland L, Maxwell GL, Fowler JM: HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J Clin Oncol. 2006, 24: 2376-2385. 10.1200/JCO.2005.03.4827.CrossRefPubMed
22.
go back to reference Leyendecker G, Herbertz M, Kunz G, Mall G: Endometriosis results from the dislocation of basal endometrium. Hum Reprod. 2002, 17: 2725-2736. 10.1093/humrep/17.10.2725.CrossRefPubMed Leyendecker G, Herbertz M, Kunz G, Mall G: Endometriosis results from the dislocation of basal endometrium. Hum Reprod. 2002, 17: 2725-2736. 10.1093/humrep/17.10.2725.CrossRefPubMed
23.
go back to reference Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N, Yamamoto T, Honda M: Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol. 2002, 48: 50-56. 10.1034/j.1600-0897.2002.01101.x.CrossRefPubMed Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N, Yamamoto T, Honda M: Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol. 2002, 48: 50-56. 10.1034/j.1600-0897.2002.01101.x.CrossRefPubMed
24.
go back to reference Ferrandina G, Legge F, Ranelletti FO, Zannoni GF, Maggiano N, Evangelisti A, Mancuso S, Scambia G, Lauriola L: Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer. 2002, 95: 801-807. 10.1002/cncr.10736.CrossRefPubMed Ferrandina G, Legge F, Ranelletti FO, Zannoni GF, Maggiano N, Evangelisti A, Mancuso S, Scambia G, Lauriola L: Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer. 2002, 95: 801-807. 10.1002/cncr.10736.CrossRefPubMed
25.
go back to reference Li W, Xu RJ, Zhang HH, Jiang LH: Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int J Gynecol Cancer. 2006, 16: 1673-1678. 10.1111/j.1525-1438.2006.00408.x.CrossRefPubMed Li W, Xu RJ, Zhang HH, Jiang LH: Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int J Gynecol Cancer. 2006, 16: 1673-1678. 10.1111/j.1525-1438.2006.00408.x.CrossRefPubMed
26.
go back to reference Chou YC, Chen YJ, Lai CR, Wang PH, Hsin C, Yuan CC: Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis. Eur J Obstet Gynecol Reprod Biol. 2006, 124: 101-105. 10.1016/j.ejogrb.2005.06.019.CrossRefPubMed Chou YC, Chen YJ, Lai CR, Wang PH, Hsin C, Yuan CC: Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis. Eur J Obstet Gynecol Reprod Biol. 2006, 124: 101-105. 10.1016/j.ejogrb.2005.06.019.CrossRefPubMed
27.
go back to reference Orejuela FJ, Ramondetta LM, Smith J, Brown J, Lemos LB, Li Y, Hollier LM: Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol. 2005, 97: 483-488. 10.1016/j.ygyno.2005.02.010.CrossRefPubMed Orejuela FJ, Ramondetta LM, Smith J, Brown J, Lemos LB, Li Y, Hollier LM: Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol. 2005, 97: 483-488. 10.1016/j.ygyno.2005.02.010.CrossRefPubMed
28.
go back to reference Taskin M, Lallas TA, Shevchuk M, Barber HR: P53 expression in adenomyosis in endometrial carcinoma patients. Gynecol Oncol. 1996, 62: 241-246. 10.1006/gyno.1996.0222.CrossRefPubMed Taskin M, Lallas TA, Shevchuk M, Barber HR: P53 expression in adenomyosis in endometrial carcinoma patients. Gynecol Oncol. 1996, 62: 241-246. 10.1006/gyno.1996.0222.CrossRefPubMed
29.
go back to reference Koshiyama M, Konishi I, Wang DP, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Naito MF, Mori T: Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status. Virchows Arch A Pathol Anat Histopathol. 1993, 423: 265-271. 10.1007/BF01606889.CrossRefPubMed Koshiyama M, Konishi I, Wang DP, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Naito MF, Mori T: Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status. Virchows Arch A Pathol Anat Histopathol. 1993, 423: 265-271. 10.1007/BF01606889.CrossRefPubMed
Metadata
Title
Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report
Authors
Giacomo Puppa
Makio Shozu
Tiziana Perin
Kazuhito Nomura
Annunziata Gloghini
Elio Campagnutta
Vincenzo Canzonieri
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2007
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-7-103

Other articles of this Issue 1/2007

BMC Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine